BioSpectrum India, a leading B2B media platform in Lifesciences space since 2003, is conducting its ranking survey.  In this survey we looked at only the Biopharma Industry with companies specialising in Biologics/Blood products/ Recombinant products/ mAbs/ Vaccines/ Insulin.  We have highlighted the companies (both MNCs and domestic players) based on their achievements in the past financial years.

A detailed questionnaire (survey form) made available on https://www.biospectrumindia.com/ to the companies in biologicals space to capture the needed information for the analysis. This was done during September 10, 2025 to October 10, 2025 (Sales revenues of all the companies are in Rs Crore). Companies shared information with us to the extent it was possible by them. We have collected information about listed companies from stock exchange, financial agencies and speaking with industry experts as well.

#The revenues considered for the analysis are biologicals sales and service figures. In several cases, where revenue figures were not available, estimates were arrived at in discussion with industry experts.

#For all the ranking purposes, we have taken the biopharma business only into consideration. Wherever 'Revenue is mentioned, it means sales turnover from the biopharma division. Therefore, revenue wherever mentioned is not necessarily the total sales turnover of the company.